Tauriga Sciences, Inc.
TAUG · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Revenue | $103 | $107 | $33 | $70 |
| % Growth | -4.4% | 221.7% | -52.5% | – |
| Cost of Goods Sold | $46 | $59 | $15 | $29 |
| Gross Profit | $56 | $48 | $18 | $41 |
| % Margin | 54.7% | 44.8% | 54.4% | 58.4% |
| R&D Expenses | $9 | $95 | $13 | $239 |
| G&A Expenses | $1,250 | $838 | $883 | $1,571 |
| SG&A Expenses | $1,385 | $1,148 | $980 | $1,663 |
| Sales & Mktg Exp. | $135 | $310 | $96 | $93 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,395 | $1,244 | $994 | $1,903 |
| Operating Income | -$1,339 | -$1,196 | -$976 | -$1,862 |
| % Margin | -1,305.5% | -1,114.3% | -2,925.2% | -2,652.6% |
| Other Income/Exp. Net | -$203 | -$540 | $144 | -$150 |
| Pre-Tax Income | -$1,542 | -$1,736 | -$832 | -$2,012 |
| Tax Expense | $67 | $419 | $436 | $191 |
| Net Income | -$1,542 | -$1,736 | -$832 | -$2,012 |
| % Margin | -1,503.5% | -1,617.5% | -2,494.6% | -2,865.8% |
| EPS | -0.005 | -0.008 | -0.003 | -0.011 |
| % Growth | 28.9% | -153.3% | 73.7% | – |
| EPS Diluted | -0.005 | -0.008 | -0.003 | -0.011 |
| Weighted Avg Shares Out | 297,002 | 282,675 | 277,979 | 193,622 |
| Weighted Avg Shares Out Dil | 297,002 | 282,675 | 277,979 | 193,622 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $67 | $419 | $436 | $191 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$1,474 | -$1,316 | -$395 | -$1,820 |
| % Margin | -1,436.7% | -1,225.9% | -1,184.7% | -2,592% |